Journal Club 2026

Next HOPA Journal Club

Thursday, November 19, 2026 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Topic area: Solids

Orange button that says click here to register

The moderator for November's Journal Club session is:

Christopher Wang, PharmD, BCOP, Clinical Pharmacy Specialist - Acute Medical Oncology, Johns Hopkins Health, Baltimore, MD

November's Journal Club presenters include:

Lauren McFalls, PharmD

PGY2 Oncology Pharmacy Resident

Allegheny General Hospital, Pittsburgh, PA

Article:

First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer

Ryan Murphy, PharmD

PGY2 Oncology Pharmacy Resident

University Hospitals Cleveland Medical Center, Cleveland, OH

Article:

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer

Featured Articles

A photo of several HOPA members posing in front of the Capitol

Advocacy

HOPA Hill Day 2026 Reaches New Milestones with Advocacy Efforts in D.C.

October 01, 2026

A record-topping number of participants united in Washington D.C. for HOPA In-Person Hill Day, bringing today’s pressing cancer care concerns and constructive policy conversations to the Capitol.

HOPA News

Late-Breaking HOPA News: RASolute 302 Breakthrough in Metastatic Pancreatic Adenocarcinoma

August 05, 2026

Michael Arnold, PharmD, discusses the very encouraging results from the RASolute 302 trial, a potential breakthrough in pancreatic cancer threapy.

HOPA News

Late-Breaking HOPA News: Precision-T: Orca-T and the Evolution of GVHD Prophylaxis in Allogeneic Transplantation

August 04, 2026

Nathan Schieldt, PharmD, BCOP, discusses allogeneic hematopoietic stem cell transplantation's place as a potentially curative therapy for high-risk hematologic malignancies and how Orca-T provides a novel approach to allo-HSCT.